Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06NUU
|
||||
| Former ID |
DNC014270
|
||||
| Drug Name |
1-benzhydryl-4-(3,3-diphenylpropyl)piperazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530438] | ||
| Formula |
C32H34N2
|
||||
| Canonical SMILES |
C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=C<br />C=CC=C5
|
||||
| InChI |
1S/C32H34N2/c1-5-13-27(14-6-1)31(28-15-7-2-8-16-28)21-22-33-23-25-34(26-24-33)32(29-17-9-3-10-18-29)30-19-11-4-12-20-30/h1-20,31-32H,21-26H2
|
||||
| InChIKey |
CLZJJBZJUIWHJT-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Voltage-dependent calcium channel subunit alpha-2/delta-1 | Target Info | Inhibitor | [530438] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.